Otenzepad

Otenzepad is a pharmacological agent that is classified as a muscarinic antagonist. It is primarily used in the treatment of cardiovascular diseases, specifically angina pectoris.

Pharmacology

Otenzepad works by blocking the muscarinic acetylcholine receptors, which are found in the heart and other areas of the body. By blocking these receptors, Otenzepad can reduce the effects of acetylcholine, a neurotransmitter that can cause the heart to beat faster and with more force. This can help to reduce the symptoms of angina pectoris, a condition that is characterized by chest pain due to reduced blood flow to the heart.

Clinical Use

Otenzepad is used in the treatment of angina pectoris. It can help to reduce the frequency and severity of angina attacks, and can also improve exercise tolerance in patients with this condition. Otenzepad is typically used in combination with other medications, such as beta blockers and calcium channel blockers, to manage angina symptoms.

Side Effects

Like all medications, Otenzepad can cause side effects. These can include dry mouth, constipation, blurred vision, and urinary retention. In rare cases, Otenzepad can cause more serious side effects, such as arrhythmia (irregular heartbeat) and hypotension (low blood pressure). Patients who experience these or any other side effects should contact their healthcare provider immediately.

Contraindications

Otenzepad is contraindicated in patients with certain medical conditions, including glaucoma, myasthenia gravis, and certain types of heart block. It should also be used with caution in patients with prostate enlargement, as it can cause urinary retention.

See Also

• Muscarinic antagonist
• Angina pectoris
• Pharmacology